This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (43) Citing Articles via Google Scholar Google Scholar Articles by McCleane, G. J. Search for Related Content PubMed PubMed Citation Articles by McCleane, G. J.

---

REGIONAL ANESTHESIA AND PAIN MANAGEMENT

Intravenous Infusion of Phenytoin Relieves Neuropathic Pain: A Randomized, Double-Blinded, Placebo-Controlled, Crossover Study

Pain Clinic, Craigavon Area Hospital, Craigavon, Northern Ireland

Address correspondence and reprint requests to Gary J. McCleane, MD, FFARCSI, Pain Clinic, Craigavon Area Hospital, Craigavon, BT63 5QQ, Northern Ireland, UK.

Neuropathic pain responds inconsistently to opioids and nonsteroidal antiinflammatory drugs. However, oral anticonvulsants have a proven analgesic effect on neuropathic pain, but may not be practical in an acute flare-up. Phenytoin was the first oral anticonvulsant used as an analgesic for neuropathic pain. There have been few studies on the parenteral analgesic effect of this drug. In this randomized, double-blind, placebo-controlled, crossover study of 20 patients with acute flare-ups of neuropathic pain, we compared a 2-h placebo infusion with a 2-h infusion of 15 mg/kg phenytoin. Overall pain, shooting pain, burning pain, paresthesia, numbness, and sensitivity were measured using a 10-cm linear visual analog score. Numbness and sensitivity were reduced in the placebo group during infusion, but not in the 7 days after infusion. In the phenytoin group, there were significant reductions in burning pain (P < 0.05), shooting pain (P < 0.001), sensitivity (P < 0.001), numbness (P < 0.05), and overall pain (P < 0.005) during the infusion period. The reduction in overall pain persisted for 1 day, in sensitivity for 2 days, and in shooting pain for 4 days after infusion. We conclude that IV infusion of 15 mg/kg phenytoin has an analgesic effect in acute flare-ups of neuropathic pain and that this relief outlives both the infusion time and plasma half-life of phenytoin.

Implications: Oral phenytoin can relieve neuropathic pain. The aim of this study was to examine the effect of IV phenytoin on neuropathic pain. The results indicate that IV phenytoin may be used to treat flare-ups of chronic neuropathic pain.

This article has been cited by other articles:

				C. E. Argoff, M.-M. Backonja, M. J. Belgrade, G. J. Bennett, M. R. Clark, B. E. Cole, D. A. Fishbain, G. A. Irving, B. H. McCarberg, and M. J. McLean Consensus Guidelines: Treatment Planning and Options Mayo Clin. Proc., April 1, 2006; 81(4_Suppl): S12 - S25. [Abstract] [Full Text] [PDF]

				S.-A. Ryder and C. F Stannard Treatment of chronic pain: antidepressant, antiepileptic and antiarrhythmic drugs CEACCP, February 1, 2005; 5(1): 18 - 21. [Abstract] [Full Text] [PDF]

				H. Chen, T. J. Lamer, R. H. Rho, K. A. Marshall, B. T. Sitzman, S. M. Ghazi, and R. P. Brewer Contemporary Management of Neuropathic Pain for the Primary Care Physician Mayo Clin. Proc., December 1, 2004; 79(12): 1533 - 1545. [Abstract] [PDF]

				J. R. Mendell and Z. Sahenk Painful Sensory Neuropathy N. Engl. J. Med., March 27, 2003; 348(13): 1243 - 1255. [Full Text] [PDF]

				M.-M. Backonja Use of anticonvulsants for treatment of neuropathic pain Neurology, September 10, 2002; 59(90052): S14 - 17. [Abstract] [Full Text]

				E. Chojnowska and G. McCleane Which Intravenous Sodium Channel Blocker for Neuropathic Pain? • Response Anesth. Analg., April 1, 2000; 90(4): 1007 - 1008. [Full Text] [PDF]